Published by Alexander Bueso on 14th July 2020
(Sharecast News) - Shares of US drug developer Rigel Pharmaceuticals shot higher on news that researchers at Imperial College were set to launch a clinical trial into the use of one of its existing treatments to help patients suffering from mild-to-moderate Covid-19 pneumonia from worsening.